PM02734

DB05158InvestigationalSmall molecule

PM02734 is a marine derived compound. PM02734 as a new antiproliferative drug demonstrating activity against a broad spectrum of tumor types: breast, colon, pancreas, lung and prostate, among others.

Mechanism: Pharmacologically active on RAC-alpha serine/threonine-protein kinase and Serine/threonine-protein kinase mTOR
Curator reviewed
Primary indication: Investigated for use/treatment in cancer/tumors (unspecified) and solid tumors.Curator reviewed
Code names: PM02734

Resolves to

Targets

P31749AKT1P42345MTOR

What you can answer from here — as of July 03, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with PM02734, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account